Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

573 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Red Cell Distribution Width Predicts Prostate-Specific Antigen Response and Survival of Patients With Castration-Resistant Prostate Cancer Treated With Androgen Receptor Axis-Targeted Agents.
Fukuokaya W, Kimura T, Onuma H, Mori K, Honda M, Inaba H, Sasaki H, Shimomura T, Miki K, Egawa S. Fukuokaya W, et al. Among authors: shimomura t. Clin Genitourin Cancer. 2019 Jun;17(3):223-230. doi: 10.1016/j.clgc.2019.04.010. Epub 2019 Apr 16. Clin Genitourin Cancer. 2019. PMID: 31080022
[Papillary adenocarcinoma of the prostate: report of 4 cases].
Miki J, Ikemoto I, Shimomura T, Kiyota H, Oisi Y, Kondo I, Madarame J, Endo K, Takahashi H. Miki J, et al. Among authors: shimomura t. Hinyokika Kiyo. 2003 Jan;49(1):21-4. Hinyokika Kiyo. 2003. PMID: 12629776 Free article. Japanese.
Values of alkaline phosphatase at the diagnosis of castration resistance and response to primary androgen deprivation therapy as predictors of subsequent metastasis in non-metastatic castration-resistant prostate cancer.
Mori K, Kimura T, Fukuokaya W, Iwatani K, Sakanaka K, Kurokawa G, Yanagisawa T, Sasaki H, Miki J, Shimomura T, Miki K, Hatano T, Endo K, Egawa S. Mori K, et al. Among authors: shimomura t. Int J Clin Oncol. 2020 Mar;25(3):479-485. doi: 10.1007/s10147-019-01541-8. Epub 2019 Sep 11. Int J Clin Oncol. 2020. PMID: 31512007
Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high-risk metastatic hormone-sensitive prostate cancer.
Yanagisawa T, Kimura T, Mori K, Suzuki H, Sano T, Otsuka T, Iwamoto Y, Fukuokaya W, Miyajima K, Enei Y, Sakanaka K, Matsukawa A, Onuma H, Obayashi K, Tsuzuki S, Hata K, Shimomura T, Miki J, Egawa S. Yanagisawa T, et al. Among authors: shimomura t. Prostate. 2022 Jan;82(1):3-12. doi: 10.1002/pros.24243. Epub 2021 Sep 24. Prostate. 2022. PMID: 34559410
Radiographic Progression at Castration-Resistant Prostate Cancer Diagnosis: A Prognostic Indicator of Metastatic Hormone-Sensitive Prostate Cancer.
Tashiro K, Kimura S, Tsuzuki S, Urabe F, Fukuokaya W, Mori K, Aikawa K, Murakami M, Sasaki H, Miki K, Miki J, Shimomura T, Yamada H, Hata K, Nishikawa H, Abe H, Watanabe K, Kimura T. Tashiro K, et al. Among authors: shimomura t. Clin Genitourin Cancer. 2024 Jun;22(3):102075. doi: 10.1016/j.clgc.2024.102075. Epub 2024 Mar 21. Clin Genitourin Cancer. 2024. PMID: 38643665
573 results